SET and MYND Domain Containing 1 (SMYD1) (N-Term) Peptide
SMYD1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SMYD1 products
- SMYD1 (SET and MYND Domain Containing 1 (SMYD1))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SMYD1 antibody (Catalog #: ARP50861_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SMYD1 (SET and MYND Domain Containing 1 (SMYD1))
- Background
-
SMYD1 acts as a transcriptional repressor. SMYD1 is essential for cardiomyocyte differentiation and cardiac morphogenesis.
Alias Symbols: BOP, ZMYND18, ZMYND22, KMT3D
Protein Interaction Partner: HDAC2,HDAC3,NACA
Protein Size: 490 - Molecular Weight
- 56 kDa
- Gene ID
- 150572
- NCBI Accession
- NM_198274, NP_938015
- UniProt
- Q8NB12
-
You are here:
